Advertisement

Topics

Therapon Skin Health Granted Patent for a Nanoparticle with UV Protection of SPF 5,000

05:21 EDT 23 Sep 2016 | PR Newswire

SPRINGDALE, Ark., Sept. 23, 2016 /PRNewswire/ -- Therapon's R & D team has developed UV radiation absorbing silicon particle based on quantum physics properties. The nanoparticles have proven to trap up to 98 percent of the full sun energy spectrum, UVA and UVB, while remaining colorless on skin.

With these nanoclusters, the future may have skin-protecting products with potential effectiveness in the 5,000 SPF range. The technology and particles are a totally new mechanism for sun protection. Rigorous testing and approval processes must come before the new breakthrough will be available in the marketplace.

When applied to the skin, the nanoclusters leave an invisible layer of protection from harmful UV rays. If use begins at an early age, they could possibly eliminate the development of all skin cancer and melanoma.

The nanoclusters were developed in a joint partnership between Theraderm's James Beckman, MD and Anatoli Ischenko, PhD of Moscow State University in Russia. They trap quantum dots of sun energy and allow it to be dissipated as harmless vibrations. This protects skin from harmful UV sunrays, which are the damaging factors responsible for 90 percent of the aging of human skin.

Beckman and Ischenko first filed for a US Patent on Beckman's idea for the nanoparticles in 2005; research has continued on the product since the patent was filed. The debut date of the new nanoclusters in the marketplace is still uncertain.

"We are hoping to partner with a pharmaceutical company soon to roll it out globally," Beckman said.

The nanoclusters particles are made by using focused lasers to vaporize sand at 5,000 degrees to get pure silicon kernels that cool while forming an annealed coating of silicon oxide. The particle size and physical composition gives them the quantum physics properties and ability to trap energy waves as particles.

ABOUT THERAPON SKIN HEALTH
Therapon Skin Health, parent company of Theraderm Clinical Skin Care, uses science to create multiple patents and products for a variety of skin concerns ranging from eradicating cancer cells to reversing inflammation symptoms and tissue damage from burns. Therapon is dedicated to providing simple solutions to complex problems by creating products that enhance skin's health and natural beauty. Visit www.theraderm.net for more information.

Press Contact:
DeMarius Davis, (479-287-4006)
WhyteSpyder, Inc.
1023 E. Millsap Rd.
www.whytespyder.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/therapon-skin-health-granted-patent-for-a-nanoparticle-with-uv-protection-of-spf-5000-300332862.html

SOURCE Therapon Skin Health

NEXT ARTICLE

More From BioPortfolio on "Therapon Skin Health Granted Patent for a Nanoparticle with UV Protection of SPF 5,000"

Quick Search
Advertisement
 

Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...